Stock fact sheet · data as of

Caring Brands, Inc. (CABR): fair value, margin of safety and Wheel Score

Ticker symbol CABR · Healthcare · Drug Manufacturers - Specialty & Generic · United States · Speculative

Close0.9000
GLS fair value0.14611 of 9 models
Margin of safety-516%price above fair value
Wheel Score15No optionsno listed options
Health-Piotroski F-score
Moat2.5/10GLS 10-year score
Market cap$8M266k shares a day
Implied vol.-no listed options
P/E-EPS -1.26
Dividend yieldnone
Beta-0.63moves less than the market
Next earnings-no date recorded

Is CABR undervalued?

Caring Brands, Inc. (CABR) closed at 0.9000 on 5 Nov 2026, 516% above the GLS average fair value of 0.1461. 1 of the 1 models that produced a number value the shares below the current price. A gap this wide usually means the market is paying for growth or a story the trailing numbers do not show yet; the models work from filed results, not forecasts, so they are conservative by design.

Only 1 of the nine models produced a value (DCF); the others need a dividend, positive free cash flow or positive book value the company does not have yet, so the average rests on a narrow base.

The nightly engine files CABR under Speculative - it is losing money or its Piotroski health score is 3 or lower - which caps its Wheel Score at 45 and keeps it out of the Sunday Scan.

Nine valuation models for CABR

Each model turns the latest filed numbers into a value per share; the GLS fair value is the simple average of the ones that produce a positive number. The last two rows are shown for reference and never enter the average. The Quote page lets you switch any model off and add your own margin of safety.

ModelValuevs priceWhat it measures
DCF0.1461-84%Present value of the projected free cash flows, discounted at the cost of capital
Graham Number--The most a defensive investor pays for the earnings and book value per share; no value tonight
Graham Growth--Graham's growth formula: EPS × (8.5 + 2 × growth), adjusted for bond yields; no value tonight
Lynch--EPS × the earnings growth rate (PEG of 1), growth capped at 25%; no value tonight
GLS Growth--EPS compounded ten years at the blended growth rate, discounted back at 15% a year; no value tonight
10 Cap--Owner's earnings (operating cash flow less maintenance capex) capitalised at 10%; no value tonight
Payback Time--Eight years of compounded free cash flow: the price at which the business pays for itself; no value tonight
DDM--Dividend discount model: next year's dividend ÷ (10% − 3% growth); needs a dividend; no value tonight
EPV--Earnings power value: current EPS capitalised at 9% with no growth; no value tonight
Zombie (liquidation)0.2300-74%Current assets less all liabilities, per share: the balance-sheet floor. Not in the average
Wall St target0.0000-100%Analysts' average 12-month price target. Not in the average

Quality and financial health

No Piotroski health score is on file for CABR (the statements it needs were not available), so the Health part of the Wheel Score counts it at half marks - 10 of 20 - rather than marking the stock down for missing data. The GLS Moat score is low at 2.5 out of 10: returns on capital, margins or the balance sheet have not shown a lasting edge yet - often a young company, a thin-margin business or one that has only recently turned profitable.

Returns on capital are thin or negative - ROIC -292.0%, ROE -300.2%, ROA -269.8% - with debt at 0.03 times equity and negative free cash flow.

Caring Brands, Inc. pays no dividend, so the DDM model does not apply and a covered-call holder earns only the premium and any price gain.

Institutional ownership scores 1/10, insider activity 5/10 and Congressional trading 5/10 on the GLS smart-money scales.

Piotroski F-score- / 9ROIC-292.0%
GLS Moat2.5 / 10ROE-300.2%
Debt / equity0.03ROA-269.8%
Free-cash-flow yield-27.6%Payout ratio0%
Institutions1 / 10Insiders · Congress5 · 5 / 10

Wheel Score 15: No options

CABR has no listed options in the nightly snapshot, so there is nothing to sell and the stock cannot be wheeled however good the business. It fails the first Wheel Trade Filter (options that actually trade), so the score stays under 70 and is shown as "No options" (15 here). The valuation and quality numbers still apply to owning the shares outright.

Volume runs at 266k shares a day on a market cap of $8M, with a beta of -0.63 - a low beta, so day-to-day moves are smaller than the market's; the Stability part of the Wheel Score rates that fair.

FilterWheel Trade FilterResultDetail
1Options that actually tradeFailsno listed options
2A real business, not a gambleFailsspeculative (a loss, or a weak Piotroski score)
3Below fair valueFailstrades 516% above our fair value
4Financially healthyPassesPiotroski F-score 6 or more out of 9 (a company with no score on file passes)
5Can repay its debtFailsdebt with no positive cash flow to repay it
6No serious red flagsPassesRed Flags score 60 or more out of 100 (earnings, margins, debt, analysts, filings and price checked the same way for every stock)
7A premium worth sellingFailsno implied volatility
8Big enoughFailsmarket cap $8M (under $1.0B)
9Not a penny stockFailsprice 0.90 (under $5)
How it ranksRatingFrom
ValueWeak516% above fair value
PremiumWeakno option data
MoatWeakmoat 2.5/10
HealthFairno Piotroski score on file - half marks
Red FlagsFairnot scored yet - half marks
Option tradingWeakno option volume data
StabilityFairbeta -0.63, $8M company

The Wheel Score ranks ~7,400 US stocks for selling cash-secured puts and covered calls: a stock must pass all 9 Wheel Trade Filters to score 70, and the score then ranks the ones that pass; the Sunday Scan is the top 10. It is updated nightly and is not a recommendation. How the Wheel Score works · the walkthrough lesson shows how it fits into a trade, start to finish.

Upcoming events

No upcoming earnings date is recorded for CABR in the nightly calendar.

Earnings, dividend, IPO, split and economic calendars for the whole market, filterable to your watchlists.

Similar stocks in Drug Manufacturers - Specialty & Generic

The 12 companies below are the closest to Caring Brands, Inc. by market cap within the Drug Manufacturers - Specialty & Generic industry, each with its own fact sheet; the Compare page puts up to eight of them side by side.

StockCloseFair valueMoSWheelMkt cap
INM
InMed Pharmaceuticals Inc.
1.75--11No options$10M
SBFM
Sunshine Biopharma, Inc.
2.65--10No options$6M
EGRX
Eagle Pharmaceuticals, Inc.
0.950062.37+98%32No options$12M
SNOA
Sonoma Pharmaceuticals, Inc.
1.11--13No options$5M
OPTH
Optimi Health Corp.
2.21--11No options$13M
YCBD
cbdMD, Inc.
0.4060--8No options$5M
GELS
Gelteq Limited Ordinary Shares
0.4611--12No options$4M
BIOE
Bio Essence Corporation
0.47000.8646+46%27No options$19M
HYEX
Healthy Extracts Inc.
1.400.6122-129%12No options$21M
AYTU
Aytu BioPharma, Inc.
1.925.29+64%28No options$21M
TXMD
TherapeuticsMD, Inc.
1.825.39+66%28Weak$21M
SHPH
Shuttle Pharmaceuticals Holdings, Inc.
5.21--10No options$25M

⚖ Compare CABR with 7 of them   All Healthcare stocks →

Scan the whole market the same way

A free GLS Equity account gets you nightly fair value and the Wheel Score on ~7,400 US stocks, a watchlist, the scanner preview and the Sunday Scan - the top 10 stocks that pass all 9 Wheel Trade Filters, emailed every week. Pro adds the full put and call scanners, unlimited watchlists with alerts and the trade journal.

Start free See the Sunday Scan

Questions about CABR

Is CABR undervalued right now?

No: at 0.9000 the stock trades 516% above the GLS average fair value of 0.1461 (data as of 5 Nov 2026), well beyond what trailing earnings, cash flow and book value support.

What is the Wheel Score of CABR and what does it mean?

CABR has no listed options in our nightly snapshot, so it cannot be wheeled; it fails the first Wheel Trade Filter (options that actually trade), stays under 70 and is shown as "No options".

What is the GLS fair value for CABR?

0.1461 per share as of 5 Nov 2026 - the simple average of the 1 valuation models (out of nine: DCF, Graham Number, Graham Growth, Lynch, GLS Growth, 10 Cap, Payback Time, DDM and EPV) that produced a positive value. The models run every night on the latest filings; the Quote page lets you switch any of them off and add a margin of safety of your own.

When does Caring Brands, Inc. report earnings next?

No upcoming earnings date is recorded for CABR in our calendar as of 5 Nov 2026; the Calendars page is refreshed every morning.

Does CABR have listed options, and how liquid are they?

No. The nightly options snapshot found no listed contracts on CABR, so the wheel strategy cannot be run on it and the Wheel Score stays under 70.

Data as of 5 Nov 2026: prices and fundamentals from Financial Modeling Prep, option data from Polygon; valuations, scores and the Wheel Score by GLS Equity's models, run nightly. Prices in USD; the close shown is the previous session's. Everything on this page is general information produced by automated models from third-party data - not a recommendation to buy, sell or trade any security or option, and not financial advice. Past performance is not indicative of future results. GLS Equity provides data and tools, not financial advice.